[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

about

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

Item

http://www.wikidata.org/entity/Q55427098

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@en

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@nl

type

Item

label

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@en

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@nl

prefLabel

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@en

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@nl

P1476

[Risk Factors of Non-small Cell Lung Cancer with Bone Metastasis after Therapy].

@en

P2093

Haibo Shen

http://www.w3.org/2001/XMLSchema#string

Yinjie Zhou

http://www.w3.org/2001/XMLSchema#string

Yuanshan Yao

http://www.w3.org/2001/XMLSchema#string

Zhenhua Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Bone metastases: When and how lung cancer interacts with bone

Progression and metastasis of lung cancer

Is there any significance of lung cancer histology to compare the diagnostic accuracies of (18)F-FDG-PET/CT and (99m)Tc-MDP BS for the detection of bone metastases in advanced NSCLC?

Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.

Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.

Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis.

Risk factors for bone metastasis in completely resected non-small-cell lung cancer.

MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.

P304

476-480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2018.06.09

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29945707

http://www.w3.org/2001/XMLSchema#string

P932

6022027

http://www.w3.org/2001/XMLSchema#string